Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY
$7.34
-$0.26-3.42%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.91% | 6.07% | 4.72% | 2.35% | -0.44% |
| Total Other Revenue | -- | -2.08% | -13.17% | 13.32% | -- |
| Total Revenue | 11.91% | 5.94% | 4.67% | 2.42% | -0.44% |
| Cost of Revenue | 11.29% | 5.24% | 4.63% | 3.27% | 0.90% |
| Gross Profit | 17.35% | 11.52% | 5.02% | -4.09% | -10.78% |
| SG&A Expenses | 17.93% | 8.53% | 11.92% | 3.30% | -13.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -0.18% | 344.46% | 2,326.52% | -16.66% | -2.96% |
| Total Operating Expenses | 11.60% | 6.12% | 5.33% | 3.00% | -0.18% |
| Operating Income | 21.30% | 0.16% | -15.56% | -12.49% | -7.55% |
| Income Before Tax | 18.25% | 12.25% | -18.92% | 94.36% | -12.08% |
| Income Tax Expenses | 16.83% | 2.48% | 22.60% | 95.31% | -8.21% |
| Earnings from Continuing Operations | 18.69% | 18.35% | -30.46% | 93.99% | -13.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -48.12% | -19.45% | 3.33% | 31.02% | 6.23% |
| Net Income | 11.91% | 17.59% | -38.11% | 123.66% | -14.69% |
| EBIT | 21.30% | 0.16% | -15.56% | -12.49% | -7.55% |
| EBITDA | 21.62% | 3.36% | -13.10% | -8.40% | -4.98% |
| EPS Basic | 11.94% | 15.87% | -37.20% | 124.71% | -15.56% |
| Normalized Basic EPS | 4.34% | -31.62% | -15.24% | 158.03% | -8.89% |
| EPS Diluted | 11.94% | 13.23% | -37.20% | 126.76% | -15.56% |
| Normalized Diluted EPS | 4.34% | -31.62% | -15.24% | 158.03% | -8.89% |
| Average Basic Shares Outstanding | 0.01% | 1.82% | -1.58% | -0.56% | 0.98% |
| Average Diluted Shares Outstanding | 0.01% | 1.82% | -1.58% | -0.56% | 0.98% |
| Dividend Per Share | -- | 22.58% | -- | 50.91% | -- |
| Payout Ratio | 0.32% | -0.24% | 0.13% | -0.59% | 0.04% |